Rime Bioinformatics
Private Company
Total funding raised: $1.8M
Overview
Rime Bioinformatics is a Paris-based service provider that addresses the technical and computational barriers faced by biologists in analyzing DNA/RNA sequencing data. The company's core mission is to democratize access to precise, high-quality bioinformatics, enabling faster research and development, particularly in the field of phage therapy. By developing and benchmarking advanced tools and delivering clear, biologist-friendly reports, Rime aims to accelerate the development of safer alternatives to antibiotics across human health, agriculture, and veterinary medicine.
Technology Platform
Integrated service platform combining continuous benchmarking of public bioinformatics tools, development of proprietary analysis methods (especially for phage/microbial genomes), and delivery via high-performance computing, resulting in biologist-friendly analytical reports.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Rime competes in the bioinformatics services market, which includes contract research organizations (CROs), academic core facilities, freelance bioinformaticians, and bioinformatics software companies. Its differentiation lies in its specialized expertise in phage genomics and its focus on making advanced analyses accessible to biologists without computational backgrounds.